Adherence to doxycycline for uncomplicated genitourinary chlamydia: A prospective observational study

Abstract Objectives Since 2020, the Center for Disease Control and Prevention (CDC) no longer recommends single‐dose azithromycin as first‐line therapy for uncomplicated genitourinary chlamydia, advising instead a 7‐day course of doxycycline. Our study investigates self‐reported adherence to the new...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Ridelman, Shira Heisler, Angela Groves
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Journal of the American College of Emergency Physicians Open
Online Access:https://doi.org/10.1002/emp2.13137
Tags: Add Tag
No Tags, Be the first to tag this record!